Bio-Path Holdings, Inc.
BPTH- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001133818
No open-market purchases or sales by Bio-Path Holdings, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Bio-Path Holdings, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 2 | 0 | −2 |
| Shares | 31.1K | 0 | −31.1K (−100.0%) |
| Value | $5.29K | $0 | −$5.29K (−100.0%) |
New holders (0)
Institutions that held Bio-Path Holdings, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
None.
Sold out (2)
Institutions that held Bio-Path Holdings, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| XTX Topco Ltd | 31,127 | $5.29K |
| Jones Financial Companies LLLP | 1 | $0 |